Arkadios Wealth Advisors Buys 1,229 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Arkadios Wealth Advisors increased its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 9.2% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 14,533 shares of the medical equipment provider’s stock after acquiring an additional 1,229 shares during the quarter. Arkadios Wealth Advisors’ holdings in Intuitive Surgical were worth $7,586,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the company. Godsey & Gibb Inc. boosted its holdings in Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock valued at $29,000 after purchasing an additional 35 shares during the period. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical in the third quarter worth $33,000. Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical during the fourth quarter valued at $36,000. Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the third quarter worth about $38,000. Finally, DT Investment Partners LLC increased its stake in Intuitive Surgical by 80.0% in the 3rd quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider’s stock worth $40,000 after acquiring an additional 36 shares during the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on ISRG shares. Leerink Partners boosted their price objective on Intuitive Surgical from $489.00 to $502.00 in a report on Thursday, October 17th. Wells Fargo & Company boosted their price target on shares of Intuitive Surgical from $549.00 to $630.00 and gave the stock an “overweight” rating in a research note on Wednesday, December 11th. Oppenheimer restated a “market perform” rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Robert W. Baird upped their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an “outperform” rating in a research note on Thursday, October 17th. Finally, Piper Sandler reaffirmed an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average target price of $554.17.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of Intuitive Surgical stock in a transaction on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total transaction of $95,225.76. Following the completion of the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. The trade was a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 108 shares of the stock in a transaction on Tuesday, November 26th. The stock was sold at an average price of $542.06, for a total value of $58,542.48. Following the completion of the sale, the chief financial officer now directly owns 8,757 shares in the company, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last ninety days. 0.80% of the stock is owned by corporate insiders.

Intuitive Surgical Trading Up 1.5 %

NASDAQ:ISRG opened at $592.64 on Friday. The company has a 50-day moving average price of $539.54 and a 200-day moving average price of $497.69. The stock has a market cap of $211.09 billion, a price-to-earnings ratio of 95.28, a P/E/G ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 12 month low of $362.14 and a 12 month high of $597.68.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion during the quarter, compared to analyst estimates of $2.01 billion. Equities analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current fiscal year.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.